Mount Sinai Hospital: Scientists Take Important Step Toward Using Retinal Cell Transplants to Treat Blindness
January 16, 2021
January 16, 2021
NEW YORK, Jan. 16 (TNSRes) -- The Icahn School of Medicine at Mount Sinai issued the following news release:
Retinal cells derived from a cadaver human eye survived when transplanted into the eyes of primate models, an important advance in the development of cell therapy to treat blindness, according to a study published on January 14 in Stem Cell Reports.
The retinal pigment epithelium (RPE), a layer of pigmented cells in the retina, functions as a barrier and regulato . . .
Retinal cells derived from a cadaver human eye survived when transplanted into the eyes of primate models, an important advance in the development of cell therapy to treat blindness, according to a study published on January 14 in Stem Cell Reports.
The retinal pigment epithelium (RPE), a layer of pigmented cells in the retina, functions as a barrier and regulato . . .